Abstract
Our laboratory has identified and characterized an X-linked severe combined immunodeficiency (XSCID) in dogs that is due to mutations in the common gamma (γc) subunit of the interleukin-2 (IL2), IL4, IL7, IL9, and IL 15 receptors. Canine XSCID, unlike genetically engineered γc-deficient mice, has a clinical and immunologic phenotype virtually identical to human XSCID. It appears that speciesspecific differences exist in the role of the γc and its associated cytokines in mice compared to their role in humans and dogs, suggesting γc-deficient dogs may be a more relevant model for studing the role of the γc in humans. We are utilizing this model for a variety of studies to address:
-
1.
Fundamental questions concerning the role of the γc in cytokine regulation and lymphocyte development.
-
2.
The pathogenesis of XSCID.
-
3.
Strategies for improving bone marrow transplantation outcome.
-
4.
Development and evaluation of strateies for gene therapy.
-
5.
Human hematopoietic stem cell development.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Rosen FS, Cooper MD, Wedgewood RJP: The primary immunodeficiencies. N Engl J Med 1995;333: 431–440.
Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, et al.: Interleukin-2 receptor g chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993;73:147–157.
Leonard WJ: Dysfunctional cytokine signaling in severe combined immunodeficiency. J Invest Med 1996;44:304–311.
Conley M, Buckley RH, Hong R, Guerra-Hanson C, Roifman CM, Brochstein JA, et al.: X-linked severe combined immunodeficiency. Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findings. J Clin Invest 1990;85:1548–1554.
Gougeon ML, Drean G, LeDeist F, Dousseau M, Fevrier M, Diu A, et al.: Human severe combined immunodeficiency disease. Phenotypic and functional characteristics of peripheral B lymphocytes. J Immunol 1990;145:2873–2879.
Conley M: X-linked severe combined immunodeficiency. Clin Immunol Immunopathol 1991; 61:S94-S99.
Buckley R, Schiff S, Schiff R, Markert ML, Williams L, Ochs H: B cell function after haploidentical stem cell transplantation in human severe combined immunodeficiency. FASEB J 1993;7:95A.
Matthews DJ, Clark PA, Herbert J, Morgan G, Armitage RJ, Kinnon C, et al.: Function of the interleukin-2 (IL-2) receptor γ-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13 and IL-15. Blood 1996; 85:38–42.
Conley M, Lavoie A, Briggs C, Brown P, Guerra C, Puck JM: Nonrandom X chromosome inactivation in B cells from carrier of X chromosome-linked severe combined immunodeficiency. Proc Natl Acad Sci USA 1988;85:3090–3094.
DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky K: Lymphoid development in mice with a targeted deletion of the interleukin g chain. Proc Natl Acad Sci USA 1995;92:377–381.
Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, et al.: Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 1995;2:223–238.
Jezyk PF, Felsburg PJ, Haskins ME, Patterson DF: X-linked severe combined immunodeficiency in the dog. Clin Immunol Immunopathol 1989;52:173–189.
Felsburg PJ, Somberg RL, Perryman LE: Domestic animal models of severe combined immunodeficiency: canine X-linked severe combined immunodeficiency and severe combined immunodeficiency in horses. Immunol Rev 1992;3:277–303.
Somberg RL, Robinson JP, Felsburg PJ: T lymphocyte development and function in dogs with X-linked severe combined immunodeficiency. J Immunol 1994;153: 4006–4015.
Henthorn PS, Somberg RL, Fimiani VM, Puck JM, Patterson DF, Felsburg PJ: IL-2Rg gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is ahomologue of the human disease. Genomics 1994;23:69–74.
Somberg RL, Tipold A, Hartnett BJ, Moore PF, Henthorn PS, Felsburg PJ: Postnatal development of T-cells in dogs with X-linked severe combined immunodeficiency. J Immunol 1996;156:1431–1435.
Felsburg PJ, Somberg RL, Krakowka GS: Acute monocytic leukemia in a dog with X-linked severe combined immunodeficiency. Clin Diag Lab Immunol 1994;1:379–384.
Snyder PW, Kazacos EA, Felsburg PJ: Histologic characterization of the thymus in canine X-linked severe combined immunodeficiency. Clin Immunol Immunopathol 1993;67: 55–67.
Buckley R; Schiff SE, Schiff RI, Roberts JL, Markert ML, Peters W, et al.: Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Sem Hematol 1993; 30:92–104.
Van Leeuwen JEM, van Tol MJD, Hoosten AM, Schellenhens PTA, van den Bergh RL, Waaijen JLM, et al.: Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation of severe combined immunodeficiency. Blood 1994;8 4:3936–3947.
Felsburg PJ, Somberg RL, Hartnett BJ, Suter, SF, Hentorn PS, Moore PF, et al.: Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency. Blood 1997;90:3214–3221.
Brooks EG, Schmalstieg FC, Wirt DP, Rosenblatt HM, Adkins LT, Lookingbill DP, et al.: A novel X-linked combined immunodeficiency disease. J Clin Invest 1990; 86:1623–1631.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Felsburg, P.J., Somberg, R.L., Hartnett, B.J. et al. Canine X-linked severe combined immunodeficiency. Immunol Res 17, 63–73 (1998). https://doi.org/10.1007/BF02786431
Issue Date:
DOI: https://doi.org/10.1007/BF02786431